Skip to main content
. 2020 Oct 16;11:5228. doi: 10.1038/s41467-020-19116-x

Fig. 1. Study design and inclusion and exclusion diagram.

Fig. 1

The SPH and HBMU data comprised EGFR mutation status and the corresponding imaging data, and was used to train and validate the deep learning score (EGFR-DLS) generated by the deep learning model. The HMU TKI-treated data comprised EGFR mutation status, and the corresponding imaging data was used for the external test of the EGFR-DLS and also used for the investigation of the prognostic value of the EGFR-DLS for TKI treatment. The HLM ICI-treated data comprised patients included in anti-PD-1 and anti-PD-L1 immunotherapy, and was used for the investigation of the prognostic value of the EGFR-DLS for immunotherapy.